CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells
Keywords: ژن ترکیبی درمانی; CCL21; IL21; Oncolytic adenoviruses; Tissue-specific promoter; Combination gene therapy;